WORLD TRADE ORGANIZATION  
ORGANISATION MONDIALE DU COMMERCE  
ORGANIZACIÓN MUNDIAL DEL COMERCIO  IP/N/1/SGP/U/2/Add.1 
16 July 2009 
 (09-3499) 
Council for Trade-Related Aspects 
of Intellectual Property Rights Original:   English/ 
 anglais/  inglés 
 
MAIN DEDICATED INTELLECTUAL PROPERTY 
LAWS AND REGULATIONS NOTIFIED UNDER 
ARTICLE 63.2 OF THE AGREEMENT 
 
SINGAPORE 
 
Addendum
 
 
 The present document reproduces the text1 of the Medicines Act 1985 Revised Edition, as 
notified by Singapore on 15 April 2009 under Ar ticle 63.2 of the Agreement (see document 
IP/N/1/SGP/4). 
 
Conseil des aspects des droits de propriété 
intellectuelle qui touchent au commerce  
 
PRINCIPALES LOIS ET RÉGLEMENTATIONS CONSACRÉES À LA 
PROPRIÉTÉ INTELLECTUELLE NOTIFIÉES AU TITRE 
DE L'ARTICLE 63:2 DE L'ACCORD 
 
SINGAPOUR 
 
Addendum  
 
 Le présent document contient le texte1 de l'Édition révisée de 1985 de la Loi sur les 
médicaments, notifiée par Singapour le 15 avril 2009 au titre de l'article 63:2 de l'Accord (voir le 
document IP/N/1/SGP/4). 
 
Consejo de los Aspectos de los Derechos de Propiedad 
Intelectual relacionados con el Comercio  
 
PRINCIPALES LEYES Y REGLAMENTOS DEDICADOS A LA PROPIEDAD 
INTELECTUAL NOTIFICADOS EN VIRTUD DEL PÁRRAFO 2 
DEL ARTÍCULO 63 DEL ACUERDO 
 
SINGAPUR 
 
Addendum  
 
 En el presente documento se reproduce el texto1 de la Ley de Medicamentos, edición revisada 
de 1985, notificada por Singapur el 15 de abril de 2009 de conformidad con el párrafo 2 del 
artículo 63 del Acuerdo (véase el documento IP/N/1/SGP/4). 
                                                      
1 In English only./En anglais seulement./En inglés solamente. IP/N/1/SGP/U/2/Add.1 
Page 2  
 
   
MEDICINES ACT 
 
(CHAPTER 176) 
 
 
 
History Act 52 of 1975  
->1985  
REVISED 
EDITION  
   
 An Act to make provisions with respect to me dicinal products and medi cal advertisements and 
matters connected therewith; and to make c onsequential amendments to the Poisons Act 
(Chapter 234). 
 
[Parts I and II: 24th June 1977; Part III, sectio ns 30, 31, 34, 35: 24th June 1977; Part V: 
24
th June 1977; Part VII, sections 54 to 75:  24th June 1977; Part VI: 15th November 1977; 
Part IV: 16th January 1981; Sections 23-29, 32, 33 , Section 76: (Not in force); Part III, with the 
exception of sections 30, 31, 34 and 35 wef 3 May 93 vide S156/93]   
 
 
Arrangement of Provisions 
 
 PART I
 
PRELIMINARY  
1 Short title and commencement.  
2 Interpretation.  
3 Meaning of “medicinal produc t” and related expressions.  
 
 
PART II  
LICENCES AND CERTIFICATES RELATING TO MEDICINAL PRODUCTS  
4 Licensing authority.  
5 General provisions as to dea ling with medicinal products.  
6 Provisions as to manufacture and wholesale dealing.  
7 Exemptions for pharmacists and practitioners.  
8 Exemption in respect of herbal remedies.  
9 General exemptions.  
10 Register of medicinal products and import licence.  
11 Application for licence.  
12 Factors relevant to determination of application for licence.  
12A Whether medicinal product subject to patent  
13 Grant or refusal of licence.  
14 Duration and renewal of licence.  
15 Provisional licences.  
16 General power to suspend, revoke or vary licences.  
17 Variation of licence on application of holder.  
18 Clinical trials and medicinal tests on animals.  
19 Provision of information to licensing authority.  
19A Protection of confidential supporting info rmation about innovative medicinal product   IP/N/1/SGP/U/2/Add.1 
 Page 3 
 
 
  19B Circumstances where protection under section 19A does not apply  
19C Licensing authority may publish information on applications  
19D No product licence to be granted on basis of previous grant  
20 Offences under this Part.  
21 Special defences under section 20.  
22 Certificates for exporters of medicinal products.  
  
PART III
 
FURTHER PROVISIONS RELATING TO DEALINGS WITH MEDICINAL PRODUCTS  
23* General sale list.  
24* Sale or supply of medicinal products not on general sale list.  
25* Sale or supply of medicina l products on general sale list.  
26* Prohibition of sale of medicinal products from automatic machines.  
27* Exemptions for doctors, dentists and veterinary  surgeons and in respect of herbal remedies.  
28* Power to extend or modify exemptions.  
29* Medicinal products on prescription only.  
30 Prohibition of sale, supply or importation of me dicinal products of specified description or of 
animal feeding stuffs incorporating such products.  
31 Adulteration of medicinal products.  
32* Protection of purchasers of medicinal products.  
33* Compliance with standards specified in monographs in certain publications.  
34 Further powers to regulate d ealings with medicinal products.  
35 Offences under this Part.  
  PART IV
 
PHARMACIES  
36 General provisions.  
37 Registration of premises.  
38 Supplementary provisions as to registration of premises.  
39 Restrictions on use of titles, descriptions and emblems.  
40 Minister may modify restrictions under section 39.  
41 Power for licensing authority to disqualify and direct removal from register.  
42 Appeal relating to disqualification.  
43 Offences under this Part.  
 
 
PART V  
CONTAINERS, PACKAGES AND IDENTIFICATION OF MEDICINAL PRODUCTS  
44 Labelling and marking of containers and packages.  
45 Leaflets.  
46 Requirements as to containers.  
47 Distinctive colours, shapes and markings of medicinal products.  
48 Offences under this Part a nd supplementary provisions.  
  
PART VI
 
PROMOTION OF SALES OF MEDICINAL PRODUCTS AND MEDICAL ADVERTISEMENTS  
49 Scope of this Part.  
50 False or misleading advertisements and representations.  
51 Prohibition of certain medical advertisements.  
52 Powers to regulate adver tisements and representations.  IP/N/1/SGP/U/2/Add.1 
Page 4  
 
  53 Power of licensing authority to require copies of advertisements.
 
  
PART VII
 
MISCELLANEOUS AND SUPPLEMENTARY PROVISIONS  
54 Application of this Act to certain articles and substances.  
55 Application of this Act to certain othe r substances which are not medicinal products.  
56 Rights of entry.  
57 Power to inspect, take sampl es and seize goods and documents.  
58 Supplementary provisions as to rights of entry and related rights.  
59 Seizure or detention of goods s ubject to prohibition or restriction.  
60 Forfeiture of goods seized.  
61 Disposal of goods forfeited  
62 Restrictions on disclosure of information.  
63 Protection for officers.  
64 Contravention due to default of other person.  
65 Warranty as defence.  
66 Offences in relation to warranties.  
67 Offences by bodies corporate.  
68 Certificate of analysis.  
69 Presumptions.  
70 Service of documents.  
71 Jurisdiction of District and Magistrate’s Courts.  
72 Composition of offences.  
72A Fees, charges, etc., collected by licensing au thority to be paid to appropriate Authority  
73 Advisory committees  
74 Regulations  
75 Application of other written law not affected  
76* Repeal and consequential amendments  
77 Act not to apply to products categorised and re gulated as health products  under Health Products 
Act 2007  
 
 
 
FIRST SCHEDULE  
DISEASES AND CONDITIONS  
 
 
 
SECOND SCHEDULE*  
AMENDMENTS TO THE POISONS ACT (CHAPTER 234)  
  Actual Provisions 
 
   IP/N/1/SGP/U/2/Add.1 
 Page 5 
 
 
  MEDICINES ACT 
 
(CHAPTER 176) 
 
An Act to make provisions with respect to me dicinal products and medi cal advertisements and 
matters connected therewith; and to make c onsequential amendments to the Poisons Act 
(Chapter 234). 
 
[Parts I and II: 24th June 1977; Part III, sectio ns 30, 31, 34, 35: 24th June 1977; Part V: 
24th June 1977; Part VII, sections 54 to 75:  24th June 1977; Part VI: 15th November 1977; 
Part IV: 16th January 1981; Sections 23-29, 32, 33 , Section 76: (Not in force); Part III, with the 
exception of sections 30, 31, 34 and 35 wef 3 May 93 vide S156/93] 
  
PART I 
 
PRELIMINARY 
 
Short title and commencement. 
1.—(1) This Act may be cited as the Medicines Act and shall come into operation on such date as the 
Minister may, by notification in the Gazette, appoint.   
 
(2) The Minister may appoint different dates for the coming into operation of the different Parts or provisions of this Act.    
Interpretation. 
2.—(1)  In this Act, unless the context otherwise requires — 
 
"administration"  means giving or applying to a human being or an animal, whether orally, by 
injection or by introduction into the body in any other way, or by external application, whether by direct contact with the body or not; and any reference in this Act to administering a substance or article is a reference to administer ing it either in its existing state or after it has 
been dissolved or dispersed in, or diluted or  mixed with, some other substance used as a 
vehicle; 
  "analysis"  includes micro-biological ass ay and “analyse” has a corresponding meaning; 
 
 "analyst" means an analyst appointed by the licensing authority; 
  "animal"  includes any bird, fish or reptile;  
"assemble" , in relation to a medicinal product,  means enclosing the product (with or without 
other medicinal products of the same description)  in a container which is labelled before the 
product is sold or supplied, or, where the produc t (with or without other medicinal products of 
the same description) is already enclosed in the container in which it is to be sold or supplied, 
labelling the container before the product is sold or supplied in it, and “assembly” has a 
corresponding meaning; 
 
"Authority" means the Health Sciences Aut hority established under the Health Sciences 
Authority Act 2001; 
 IP/N/1/SGP/U/2/Add.1 
Page 6  
 
  "Chief Executive of the Authority" means the person appointed under section 15 of the Health 
Sciences Authority Act 2001 to be th e Chief Executive of the Authority; 
 
"clinical trial"  means an investigation or  series of investigations consisting of the 
administration of one or more medicinal products  of a particular description by, or under the 
direction of —   
   (a) a doctor or dentist to one or more of his patients; or  
(b) two or more doctors or dentists, each pr oduct being administered by or under the 
direction of one or other of those doctors or  dentists to one or more of his patients, 
 
where (in any such case) there is evidence that  medicinal products of that description have 
effects which may be beneficial to the patient or patients in question and the administration of 
the product or products is for the purpose of ascertaining whether, or to what extent the 
product has, or the products have, those or any other effects, whether beneficial or harmful; 
 
"composition" , in relation to a medicinal product,  means the ingredients of which it consists 
and the proportions, and the degrees of strength, quality and purity, in which those ingredients 
are contained in it respectively; 
 
"container" , in relation to a medicinal product,  means the bottle, jar, box, packet or other 
receptacle which contains or is to contain it, not being a capsule, cachet, or other article in 
which the product is or is to be administered, and where any such receptacle is or is to be 
contained in another such receptacle, includ es the former but does not include the latter 
receptacle; 
 
 "contravention"  includes failure to comply  and “contravene” has a corresponding meaning; 
 
"dentist" means a person registered under the De ntal Registration Act (Cap. 76) whose name 
appears in the first division of the Register of Dentists; 
 
 "disease"  includes any injury, ailment or adverse condition whether of body or mind; 
  "doctor"  means a person registered under the Medical Registration Act;    
Cap. 174. 
 
"herbal remedy"  means a medicinal product cons isting of a substance produced by subjecting 
a plant or plants to drying, crushing or other process or of a mixture whose ingredients are two or more substances so produced, or of a co mbination of such mixture with water or such 
other inert substances as the licensing authority may, by notification in the Gazette, specify; 
 
"hospital"  includes any institution for the rece ption and treatment of the sick and designated 
as a hospital by the Minister for the purposes of this Act; 
 
"import"  means import into Singapore wh ether by land, sea or air and “export” has a 
corresponding meaning; 
 
"ingredient" , in relation to the manufacture or  preparation of a substance, includes anything 
which is the sole active ingredient of th at substance as manufactured or prepared; 
  IP/N/1/SGP/U/2/Add.1 
 Page 7 
 
 
  "labelling" , in relation to a container or pack age of medicinal products, means affixing to or 
otherwise displaying on it a notice describing or otherwise relating to the contents, and “label” has a corresponding meaning; 
  "leaflet"  includes any written information; 
 
 "licensing authority" means the appropriate licensing authority as defined in section 4 (1); 
 
"manufacture" , in relation to a medicinal pr oduct, includes any process carried out in the 
course of making the product, but does not include dissolving or dispersing the product in, or 
diluting or mixing it with, some other subs tance used as a vehicle for the purpose of 
administering it; 
 
"medicinal test on animals"  means an investig ation or series of investigations consisting of 
any of the following:  
 
(a) the administration of a medicinal product of a particular description to one or more animals, where there is evidence th at medicinal products of that description 
have effects which may be beneficial to, or otherwise advantageous in relation to, that 
animal or those animals, and the product is administered for the purpose of ascertaining whether, or to what extent, it has those or any other effects, whether 
advantageous or otherwise; 
 
(b) the administration of a medicinal product to one or more animals in circumstances 
where there is no such evidence as is menti oned in paragraph (a), and the product is 
administered for the purpose of ascertaining whether, or to what extent, it has any 
effects relevant to a medicinal purpose; 
 
(c) the administration of any substance or article, other than a medicinal product, to one or more animals for the purpose of ascertaining whether it has any effects relevant to a medicinal purpose or whether th ere is evidence that it has effects which 
may be beneficial to, or otherwise advantag eous in relation to, that animal or those 
animals; 
 
"midwife" means a registered midwife with in the meaning of the Nurses and Midwives 
Act 1999; 
 
 "Minister"  means —   
   (a) except as provided in paragraph (b), the Minister for Health; and  
(b) for the purpose of performing any function under this Act (whether by the making of any regulations or order or otherwise) where the function is performed exclusively 
in relation to veterinary medicinal products  and animals, the Minister for National 
Development; 
 
"nurse" means a registered nurse or enrolled nurse within the meaning of the Nurses and 
Midwives Act 1999; 
 
"package" , in relation to any medicinal product,  means any box, packet or other article in 
which one or more containers of the products ar e or are to be enclosed , and, where any such 
box, packet or other article is or is to be itsel f enclosed in one or more boxes, packets or other 
articles, includes each of the boxes, packets or articles in question; IP/N/1/SGP/U/2/Add.1 
Page 8  
 
   
"pharmacist" means a person who is register ed as a pharmacist under the Pharmacists 
Registration Act 2007 and has in force a valid practising certificate issued under that Act; 
  "plant"  includes any part of a plant; 
 
 "practitioner"  means a doctor, dentist or veterinary surgeon; 
 
"product licence”, “manufacturer’s licence” and “wholesale dealer’s licence"  have the meanings ascribed to them under sections 5 a nd 6 and include any such provisional licence; 
 
"registered pharmacy"  means premises for the time being entered in the register under section 37; 
 
"retail pharmacy business"  means a business (not being a professional practice carried out by 
a practitioner) which consists of or includes the retail sale of medicinal products other than 
medicinal products on a general sale list; 
 
"retail sale" , in relation to a medicinal produc t, shall have the meaning ascribed to it under 
subsection (2); 
 
"sell" includes barter, and also includes offering or attempting to sell, or receiving for sale, or 
having in possession for sale, or exposing for sale, or sending or delivering for sale, or causing or allowing to be sold, offered or exposed for sale, and “sale” and “sold” have 
corresponding meanings; 
 
"substance"  means any natural or artificial substa nce whether in solid or liquid form or in the 
form of gas or vapour; 
  "supply"  includes having in possession for the purpose of supply;  
"treatment" , in relation to disease, includes an ything done or provide d for alleviating the 
effects of the disease, whether it is done or provided by way of cure or not; 
 
"veterinary medicinal products"  means medici nal products which are manufactured, sold, 
supplied, imported or exported for the purpose of  being administered to animals, but not for 
the purpose of being administered to human beings; 
 
"veterinary surgeon"  means a person who holds  a veterinary qualification approved by the 
Minister and who is licensed to treat, vaccinate or inoculate animals or birds under section 68 
(1) of the Animals and Birds Act;    
Cap. 7. 
 
"wholesale dealing" , in relation to a medicinal product, shall have the meaning ascribed to it 
under subsection (2). 
 (2) In this Act any reference to — 
 
(a) selling anything by way of wholesale deali ng is a reference to selling it to a person as 
being a person who buys it for the purpose of selling or supplying it in the course of a business carried on by that person except that it does not include any such sale by the person 
who manufactured it;  IP/N/1/SGP/U/2/Add.1 
 Page 9 
 
 
   
(b) selling by retail, or to retail sa le, is a reference to selling a s ubstance or article to a person 
as being a person who buys it otherwise than for a purpose specified in paragraph (a); and 
 
(c) supplying anything in circumstances corre sponding to retail sale is a reference to 
supplying it, otherwise than by way of sale, to a person as being a person who receives it for a 
purpose other than that of selling or supplying. 
 
Meaning of “medicinal product” and related expressions. 
3.—(1) Subject to the following provisio ns of this section, in this Act 
 
"medicinal product"  means any substance or ar ticle (not being an instrument, apparatus or 
appliance) which is manufactured, sold, supp lied, imported or exported for use wholly or 
mainly in either or both of the following ways:   
 
(a) use by being administered to one or  more human beings or animals for a 
medicinal purpose; 
 
(b) use as an ingredient in the preparation of a substance or article which is to be 
administered to one or more human beings or animals for a medicinal purpose. 
 
(2) In this Act, 
  "a medicinal purpose"  means any one or more of the following purposes:      (a) treating or preventing disease; 
 
  (b) diagnosing disease or ascertaining the existence, degree or extent of a 
physiological condition; 
   (c) contraception;  
  (d) inducing anaesthesia; 
   (e) otherwise preventing or interfering w ith the normal operation of a physiological 
function, whether permanently or temporaril y, and whether by way of terminating, 
reducing or postponing, or increasing or acceler ating, the operation of that function or 
in any other way. 
 (3) Notwithstanding anything in subsection (1), in this Act “medicinal product” does not include any 
substance or article which is manufactured for use w holly or mainly by being administered to one or 
more human beings or animals, where it is to be administered to them —  
 (a) in the course of the business of the manufacturer or on behalf of the manufacturer in the 
course of the business of a laboratory or researc h establishment carried on by another person; 
  (b) solely by way of a test for ascertaining what effects it has when so administered; and 
 
 (c) in circumstances where the manufacturer has no knowledge of any evidence that those 
effects are likely to be beneficial to those human beings, or beneficial to, or otherwise 
advantageous in relation to, those animals, as the case may be, 
 IP/N/1/SGP/U/2/Add.1 
Page 10  
 
  and which (having been so manufactured) is not sold , supplied or exported for use wholly or mainly 
in any way not fulfilling all the conditions speci fied in paragraphs (a), (b) and (c).   
 (4) In this Act, “medicinal product” shall also be taken not to include — 
 
 (a) substances used in dental surgery for filling dental cavities; 
 
(b) bandages and other surgical dressings, except medicated dressings where the medication has a palliative or curative function which is not limited to sterilising the dressings; and 
 
(c) substances and articles of such other description or classes as may be specified by order 
made by the Minister. 
 (5) Where in accordance with sub sections (1) to (4) a substance or  article is a medicinal product 
immediately after it has been manufactured, imported or exported as mentioned in subsection (1), or 
immediately after the first occasion on which it has been sold or supplied as mentioned in that 
subsection, then it shall not cease to be a medi cinal product for the purposes of this Act by reason 
only that, at any subsequent time, it is sold, supplie d, imported or exported for use wholly or mainly 
in a way other than those specified in subsection (1).    (6) For the purposes of this Act, medicinal products are of the same description if — 
 
 (a) they are manufactured to the same specification; and  
(b) they are, or are to be, sold, supplied, imported or exported in the same pharmaceutical 
form, 
 
and in this Act “description”, in relation to medi cinal products, shall be construed accordingly.   
 (7) For the purposes of this Act a document, adve rtisement or representation shall be taken to be 
likely to mislead as to the uses or effects of medicinal products of a particular description if it is likely 
to mislead as to any of the following matters: 
 
(a) any purposes for which medicinal products of that description can with reasonable safety be used; 
  (b) any purposes for which such products cannot be so used; and 
 
(c) any effects which such products when used, or  when used in any particular way referred to 
in the document, advertisement or representa tion, produce or are intended to produce. 
  
PART II 
 
LICENCES AND CERTIFICATES RELATING TO MEDICINAL 
PRODUCTS 
 
Licensing authority. 
4.—(1) For the purposes of this Part, the authority responsible for the grant, renewal, variation, 
suspension and revocation of licences and certificates shall be —   IP/N/1/SGP/U/2/Add.1 
 Page 11 
 
 
   (a) except as provided in paragraph (b), the Chief Executive of the Authority; and 
 
(b) the Director-General, Agri-food and Veterina ry Services appointed under section 3 (1) of 
the Animals and Birds Act (Cap. 7) in respect of any function to be performed under this Act 
exclusively in relation to veterina ry medicinal products and animals. 
 
 (2) Any function conferred on the licensing authority by  this Act may be performed by such officers 
as the licensing authority may designate, subject to his general direction and control.   
 
(3) Any person to whom a licensing authority refus es to grant, renew or vary a licence or whose 
licence has been suspended or revoked may appeal to  the Minister whose decision shall be final.   
 
General provisions as to dealing with medicinal products. 
5.—(1) Except in accordance with a lic ence granted for the purposes of this section (referred to in this 
Act as a product licence) no person shall in circumstances to which this section applies — 
  (a) sell, supply or export any medicinal product;   (b) procure the sale, supply or exportation of any medicinal product; or  
(c) procure the manufacture or assembly of any medicinal product for sale, supply or 
exportation. 
 (2) No person shall import any medicinal product except in accordance with a product licence or an 
import licence.   
 
(3) In relation to an imported medicinal product, this  section shall apply to circumstances in which the 
person selling, supplying or exporti ng the medicinal product in question, or procuring the sale, supply 
or exportation or the manufacture or assembly for sal e, supply or exportation of that product, has 
himself imported the product or procured its importation.    
(4) In relation to any medicinal product which has no t been imported, this section shall apply to any 
circumstances in which the person selling, supplying or exporting the medicinal product in question, 
or procuring the sale, supply or exportation or the manufacture or assembly for sale, supply or 
exportation of that product, is responsib le for the composition of the product.   
 
(5) For the purposes of subsection (4), a person shall be taken to be responsible for the composition of 
a medicinal product if —  
(a) he procures the manufacture of the product to his order by another person, where the order 
specifies, or incorporates by reference to some  other document, particulars of the composition 
of the product ordered, whether those particular s amount to a complete specification or not; or 
 
(b) he manufactures the product otherwise than in pursuance of an order which fulfils the 
conditions specified in paragraph (a). 
 
Provisions as to manufacture and wholesale dealing. 
6.—(1) This section shall have effect without prejudice to section 5.   
 (2) No person shall manufacture or assemble an y medicinal product except in accordance with a 
licence granted for the purposes of this subsection (refe rred to in this Act as a manufacturer’s licence).   
 IP/N/1/SGP/U/2/Add.1 
Page 12  
 
  (3) No person shall sell any medicinal product by way of wholesale dealing except in accordance with 
a licence granted for the purposes of this subsection (referred to in this Act as a wholesale dealer’s 
licence).    (4) A manufacturer’s licence shall not have effect so  as to authorise the manufacture or assembly of 
medicinal products of any description for sale or supply to any other person, or for exportation, 
unless —  
(a) the holder of the licence is also the holde r of a product licence which is applicable to 
medicinal products of that description; or 
 
(b) the products are manufactured or assembled to  the order of a person who is the holder of 
such a product licence, 
 and the products are manufactured or assembled in accordance with that product licence.   
 
Exemptions for pharmacists and practitioners. 
7.—(1) The restrictions imposed by sections 5 and 6 shall not apply to anything which is done in a 
registered pharmacy or hospital by or u nder the supervision of a pharmacist — 
 
(a) in preparing or dispensing a medicinal product in accordance with a prescription given by 
a practitioner; 
  (b) in assembling a medicinal product; or  
(c) in procuring the preparation or dispensi ng of a medicinal product in accordance with a 
prescription given by a practitioner, or in procuring the assembly of a medicinal product. 
 (2) The restrictions imposed by sections 5 and 6 sha ll not apply to the preparation or dispensing in a 
registered pharmacy of a medicinal product by or und er the supervision of a pharmacist in accordance 
with a specification furnished by the person to whom  the product is or is to be sold or supplied, 
where — 
 
(a) the product is prepared or dispensed for ad ministration to that person or to a person under 
his care; or 
 
(b) the product, not being a vaccine, plasma or serum, is prepared or dispensed for 
administration to an animal which is in the possession or under the control of that person. 
 (3) Without prejudice to subsections (1) and (2), the restrictions imposed by sections 5 and 6 shall not 
apply to anything which is done in a registered pharm acy or hospital by or under the supervision of a 
pharmacist —  
(a) in preparing or dispensing a medicinal pr oduct for administration to a person where the 
pharmacist is requested by or on behalf of that person to do so in accordance with the 
pharmacists own judgment as to the treatment re quired, and that person is present in the 
pharmacy at the time of the request in pursuan ce of which that product is prepared or 
dispensed; or 
 
(b) in preparing a stock of medicinal products w ith a view to dispensing them as mentioned in 
subsection (1) (a) or (2) or in paragraph (a). 
  IP/N/1/SGP/U/2/Add.1 
 Page 13 
 
 
  (4) The restrictions imposed by sections 5 and 6 shall not apply to the preparation, dispensing and 
assembly of any medicinal product by or under th e supervision of a practitioner for the purpose of 
administration to a patient or animal under his care.    (5) The exemptions conferred by subsections (1) to (4) shall not apply to veterinary biologics except 
where such veterinary biologics are prepared in a veterinary centre.   
 (6) For the purpose of subsection (5) —  
"veterinary biologics"  means aggressions, serums, viruses, toxins, tuberculin, mallein, 
Johnin, abortin, vaccines, micro-organisms eith er living or killed, and products of micro-
organisms intended for use in the treatment or  diagnosis of diseases of animals and birds; 
 
"veterinary centre"  means a veterinary centre established under section 65 of the Animals and Birds Act.   
 
Cap. 7. 
 
Exemption in respect of herbal remedies. 
8.—(1) The restrictions imposed by sections 5 and 6 shall not apply to the importation, sale, supply, 
manufacture or assembly of any herbal remedy where — 
 
(a) the remedy is manufactured or assembled on premises of which the person carrying on the business is the occupier and which he is able  to close so as to exclude the public; and 
 
(b) the person carrying on the business sells or supplies the remedy for administration to a 
particular person after being requested by or on  behalf of that person and in that person’s 
presence to use his own judgment as to the treatment required. 
 (2) Those restrictions also shall not apply to the im portation, sale, supply, manufacture or assembly of 
any herbal remedy where the process to which the plant or plants are subjected in producing the 
remedy consists only of drying, crushing or comminu ting, and the remedy is, or is to be, sold or 
supplied without any written recommendation (whether by means of a labelled container or package 
or a leaflet or in any other way) as to the use of the remedy.    
General exemptions. 
9.—The Minister may by order — 
 
(a) provide that, in relation to any medici nal product which was available for sale in 
Singapore immediately before the commencement of this Part, sections 5 and 6 shall have 
effect only after such period as may be specified in the order; and 
 
(b) provide for such other exemptions from the restrictions imposed by sections 5 and 6 as he 
thinks fit. 
 
Register of medicinal products and import licence. 
10.—(1) The licensing authority shall maintain a regi ster in which shall be entered all medicinal 
products in respect of which product licences ha ve been granted and remain in force.   
 
(2) The register shall be in such form and contai n such particulars as the licensing authority may 
determine.    IP/N/1/SGP/U/2/Add.1 
Page 14  
 
  (3) The licensing authority may, on application by a person who is not the holder of a product licence, 
grant an import licence to that person to import any medicinal product for sale or supply where the licensing authority is satisfied that that product is  in all respects the same as a medicinal product 
registered under subsection (1).    Application for licence. 
11.—(1) Any application for the grant of a licence under this Part shall be made to the licensing 
authority and shall be made in such form and manne r, and shall contain, or be accompanied by, such 
information, documents, samples and other mate rial, as the licensing authority may require.   
 
(2) Any such application shall indicate the descripti ons of medicinal products in respect of which the 
licence is required, either by speci fying the descriptions of medicinal products in question or by way 
of an appropriate general classification.    
Factors relevant to determinatio n of application for licence. 
12.—(1) Subject to the following provisions of this Part, in dealing with an application for a product 
licence the licensing authority shall in pa rticular take into consideration — 
  (a) the safety of medicinal products of each description to which the application relates; 
 
(b) the efficacy of medicinal products of each  such description for the purposes for which the 
products are proposed to be administered; 
 
(c) the quality of medicinal products of each su ch description, according to the specification 
and the method or proposed method of manufacture of the products, and the provisions proposed for securing that the products as sold  or supplied will be of that quality; and 
 
(d)  whether the grant of a product licence for th e medicinal products to which the application 
relates will be in the public interest. 
 (2) Where any such application indicates that th e purposes for which the licence is required relate 
(wholly or partly) to medicinal prod ucts which have been or are to be  imported, then in dealing with 
the application, in so far as it relates to such pr oducts, the licensing authority shall also take into 
consideration in particular the methods, standard s and conditions of manufacture of those products 
and may, if he thinks fit, require the production by the applicant of any one or more of the following: 
 
(a) an undertaking, given by the manufacturer of  any such products, to permit the premises 
where they are or are to be manufactured, and the operations carried on or to be carried on in 
the course of manufacturing them, to be inspected by or on behalf of the licensing authority; 
 
(b) an undertaking, given by or on behalf of th e manufacturer of any such products, to comply 
with any prescribed conditions or any conditions  attached to the licence by the licensing 
authority; 
 
(c) a declaration, given by or on behalf of th e manufacturer of any such products, that, in 
relation to the manufacture of those products, any requirements imposed by or under the law 
of the country in which they are or are to be manufactured have been or will be complied with. 
 
(3) In dealing with an application for a manuf acturer’s licence the licensing authority shall in 
particular take into consideration —   (a) the operations proposed to be ca rried out in pursuance of the licence;  IP/N/1/SGP/U/2/Add.1 
 Page 15 
 
 
   
 (b) the premises in which those operations are to be carried out;  
(c) the equipment which is or will be availa ble on those premises for carrying out those 
operations; 
 
(d) the qualifications of the persons under who se supervision those operations will be carried 
out; and 
 
(e) the arrangements made or to be made for securing the safekeeping of, and the maintenance 
of adequate records in respect of, medicina l products manufactured or assembled in pursuance 
of the licence. 
 (4) In dealing with an application for a wholesal e dealer’s licence the licensing authority shall in 
particular take into consideration — 
 
(a) the premises in which medicinal products of  the descriptions to which the application 
relates will be stored; 
 
(b) the equipment which is or will be availa ble for storing medicinal products in those 
premises; 
 
(c) the equipment and facilities which are or w ill be available for distributing medicinal 
products from those premises; and 
 
(d) the arrangements made or to be made for securing the safekeeping of, and the 
maintenance of adequate records in respect of , medicinal products stored in or distributed 
from those premises. 
 
Whether medicinal product subject to patent. 
12A. —(1)   Subject to the provisions of this Part, in  dealing with an application for a product licence, 
the licensing authority shall consider whether a patent  under the Patents Act (Cap. 221) is in force in 
respect of any medicinal product to which the application relates and, if so, whether — 
  (a)  whether the applicant is the proprietor of the patent; or   (b)  if he is not the proprietor of the patent, whether — 
 
(i)  the proprietor has given his consent to or has acquiesced in the grant of the licence 
to the applicant; or 
 
(ii)  the patent is invalid or will not be infringed by the doing of the act for which the 
licence is sought. 
 
(2)   Unless the licensing authority otherwise determ ines, an applicant for a product licence shall, at 
the time of his application and at such other time as the licensing authority may require, make and furnish to the licensing authority a d eclaration in the prescribed form — 
 
(a)  stating whether a patent under the Patents Act is in force in respect of any medicinal 
product to which the application relates; 
 
(b)  if he states that there is such a patent, st ating whether he is the proprietor of the patent; 
and IP/N/1/SGP/U/2/Add.1 
Page 16  
 
   
 (c)  if he states that he is not the proprietor of the patent, stating —    (i)  the name and other particulars of the proprietor of the patent;  
  (ii)  whether — 
 
(A)  the proprietor has consented to or has acquiesced in the grant of the 
licence to the applicant; or 
 
(B)  in his opinion and to the best of his belief, the patent is invalid or will not 
be infringed by the doing of the act for which the licence is sought; and 
   (iii)  such other information as may be prescribed.  
(3)   The licensing authority may, if the applicant has declared that in his opinion and to the best of his 
belief the patent is invalid or will not be infringe d by the doing of the act for which the licence is 
sought, or if the licensing authority considers it a ppropriate in any particular case, require the 
applicant to do the following within such time as the licensing authority may determine: 
 
(a)  serve on the proprietor of the patent under the Patents Act that is in force in respect of a 
medicinal product to which the application relates, a notice in the prescribed form of his 
application; and 
 
(b)  furnish to the licensing authority such evidence of the service as the licensing authority 
may require. 
 
(4)   The licensing authority need not determine the application until the applicant has complied with 
subsection (2) and, where applicable, subsection (3),  to the reasonable satisfaction of the licensing 
authority.    (5)   If the licensing authority is satisfied that a no tice referred to in subsection (3) ( a) has been served 
on the proprietor of the patent, the licensing author ity may grant the licence to the applicant if the 
proprietor has not, before the expiration of the pe riod prescribed for the purposes of this subsection — 
 
(a)  applied for the order or declaration by a court or the Registrar of Patents or a Deputy 
Registrar of Patents holding office under the Pa tents Act (Cap. 221), as specified in that 
notice; and 
  (b)  given written notice to the licensing authorit y stating that such application has been made. 
 (6)   The licensing authority may gran t the licence to the applicant if — 
 
(a)  application for the order or declaration re ferred to in subsection (5) (a) has been made; 
and 
 
(b)  at the expiration of the period prescribed for the purposes of this subsection, the order or declaration has not been obtained. 
 
(7)   For the purpose of subsection (1), the licen sing authority may rely upon, and shall not be 
concerned to inquire into the truth of any st atement made in the declaration furnished under 
subsection (2).     IP/N/1/SGP/U/2/Add.1 
 Page 17 
 
 
  (8)   This section applies only to an application for a product licence made on or after the date of 
commencement of the Medicines (Amendment) Act 2004.    
Grant or refusal of licence. 
13.—Subject to the provisions of this Act, on any ap plication to the licensing authority for a licence 
under this Part the licensing authority — 
  (a) may grant a licence containing such provisions as he considers appropriate; or  
(b) if, having regard to the provisions of this Act, he considers it necessary or expedient to do 
so, may refuse to grant a licence. 
 
Duration and renewal of licence. 
14.—(1) Subject to the following provisions of this  section, every licence granted under this Part, 
unless previously revoked, shall be for such period as may be prescribed.   
 
(2) Any such licence, if it has not been revoked, ma y, on the application of the holder of the licence, 
be renewed by the licensing authority for the prescrib ed period or for such shorter period as he may 
determine.    (3) On an application to the licensing authority  for the renewal of a licence under this Part, the 
licensing authority — 
 
(a) may renew the licence, with or without modifications, for such further period as is mentioned in subsection (2); 
 
(b) may grant to the applicant a new licence containing such provisions as the licensing 
authority considers appropriate; or 
 
(c) if, having regard to the provisions of this Act, he considers it necessary or expedient to do 
so, may refuse to renew the licen ce or to grant a new licence. 
 
(4) Where an application for the renewal of a li cence under this Act has been duly made, the licence 
shall not cease to be in force by virtue of subsections  (1), (2) and (3) before the licensing authority has 
determined the application.    
Provisional licences. 
15.—(1) The Minister may by regulations provide for the issue of provisional licences to such persons 
and on such terms as may be prescribed.    (2) Section 12 shall not have effect in rela tion to applications for provisional licences.   
 
General power to suspend, revoke or vary licences. 
16.—(1) Subject to subsection (3), the licensing authority may suspend a licence under this Part for 
such period as the authority may determine or may revoke, or vary the provisions of, any such licence.    (1A)   Without prejudice to the generality of subsection (1), the licensing authority may, upon the request of the holder of a licence, revoke the licence.   
 
(1B)   Without prejudice to the generality of subsection (1), the licensing authority may, upon an application by any interested person, revoke  a product licence if he is satisfied  
that —  IP/N/1/SGP/U/2/Add.1 
Page 18  
 
  (a)  a court, or the Registrar of Patents or a Deputy Registrar of Patents holding office under 
the Patents Act (Cap. 221), has determined that th e doing of an act authorised by the licence 
infringes a patent under the Patents Act; 
 
(b)  the person who made the declaration refe rred to in section 12A (2) in support of the 
application for the licence has been convicted fo r an offence under section 20 in respect of the 
declaration or any document furnished in support of a statement made in the declaration; or 
  (c)  a court has determined that the declaration —  
  (i)  contains a statement that is false or misleading in a material particular; or 
   (ii)  omits to disclose any matter that is material to the application,  and the determination or  conviction (as the case may be) is final.   
 
(2) The suspension or revocation of a licence under th is section may be total or may be limited to 
medicinal products of one or more  descriptions or to medicinal products manufactured, assembled or 
stored in any particular premises or in  a particular part of any premises.   
 (3) Where the licensing authority proposes to exerci se any power conferred by this section, he shall 
serve on the holder of the licence a notice giving partic ulars of the suspension, revocation or variation 
and of the reasons for his decision to su spend, revoke or vary the licence.   
 (4)   For the purposes of subsection (1B), a determination or conviction is final if — 
 
 (a)  it is upheld on appeal, review or revision; 
  (b)  it is not subject to further appeal;   (c)  it is not appealed against within the permitted time; or  
 (d)  any appeal against it is or is deemed to be withdrawn. 
 
Variation of licence on application of holder. 
17.—Without prejudice to any power exercisable by vi rtue of section 16, the licensing authority may, 
on the application of the holder of a licence under this Part, vary the provisions of the licence in 
accordance with any proposals contained in the application, if he is sa tisfied that the variation will not 
adversely affect the safety, quality or efficacy of medicinal products of any description to which the 
licence relates.  
Clinical trials and medicinal tests on animals. 
18.—The Minister may by regulations provide for — 
 
(a) the conduct of clinical trials, the issue of clin ical trial certificates, the exemption of clinical 
trials from sections 5 and 6; 
 
(b) the conduct of medicinal tests on animals, the issue of animal test certificates, the 
exemption of medicinal tests on animals from sections 5 and 6; and 
  IP/N/1/SGP/U/2/Add.1 
 Page 19 
 
 
  (c) the control, housing and other restrictions  in the sale, supply, manufacture, importation 
and exportation of animal feeding stuffs in which medicinal products are incorporated, 
 and for any matter ancillary or incidental thereto.  Provision of information to licensing authority. 
19.—(1) Where an application has been made to th e licensing authority for a licence under this Part 
the licensing authority, before determining the appli cation, may request the applicant to furnish to the 
licensing authority such information relating to the application as the licensing authority may consider necessary and, where any such requ est has been made the licensing authority shall not be required to 
determine the application until either — 
  (a) the information requested has been furnished to him; or  
(b) it has been shown to his reasonable satisfacti on that the applicant is unable to furnish the 
information. 
 (2) The licensing authority may serve on the holder of a licence under this Part, a notice requiring him, within such time as may be specified in the notice, to furnish to the licensing authority 
information of any description specified in the notice.    Protection of confidential supporting information about innovative medicinal product. 
19A. —(1) Where the licensing authority receives, or has received not more than 5 years before the 
commencement of the Medicines (Amendment) Act 1998, an innovative medicinal product 
application and confidential suppor ting information, the licensing authority, during the protected 
period in relation to that conf idential supporting information — 
 
(a)  shall take reasonable steps to ensure that that confidential supporting information is kept 
confidential to the licensing authority; and 
 
(b)  shall not use that confidential supporti ng information for the purposes of determining 
whether to grant any other application. 
 
(2) For the purposes of this section and section 19B, unless the context otherwise requires —   "application" means an application for a product licence;  
 "confidential information" includes —   
   (a)  trade secrets; and  
(b)  information that has commercial value that would be, or would be likely to be, 
diminished by disclosure; 
 
 "confidential supporting information" mean s confidential information given —   
   (a)  in, or in relation to, an innova tive medicinal product application; and 
 
(b)  about the medicinal product that is or was, as the case may be, the subject of that 
application; 
 IP/N/1/SGP/U/2/Add.1 
Page 20  
 
   "innovative medicinal product application" means —   
 
(a)  in relation to an application made  after the commencement of the Medicines 
(Amendment) Act 1998, an application that refers to a substance — 
 
(i)  that is an ingredient in the manufacture or preparation of the medicinal 
product to which the application relates; and 
   (ii)  that has not, before that appli cation is received by the licensing authority, 
been referred to in any other applica tion as an ingredient in the manufacture 
or preparation of the medicinal product; and 
 
(b)  in relation to an application made before the commencement of the Medicines 
(Amendment) Act 1998, an application that referred to a substance — 
 
(i)  that is or was, as the case may be, an ingredient in the manufacture or 
preparation of the medicinal product to  which the application related; and 
 
(ii)  that had not, before that application was received by the licensing authority, been referred to in any other application as an ingredient in the manufacture or preparation of the medicinal product; 
 
"licensing authority" includes any officer designated by the licensing authority under section 4(2) to determine an application for a product licence; 
 
"protected period" , in relation to confidentia l supporting information relating to an innovative 
medicinal product application received by the li censing authority, means a period of 5 years 
from the date the innovative medicinal product ap plication is or was, as the case may be, 
received by the licensing authority. 
 
Circumstances where protection under section 19A does not apply. 
19B.—(1) Notwithstanding section 19A, the licensing authority may, during the protected period in 
relation to confidential supporting information — 
 
(a)  disclose that confidential supporting info rmation, or use that confidential supporting 
information for the purposes of determining whet her to grant any application other than the 
application to which it relates or related, as the case may be — 
 
(i)  with the consent of the applicant who made the application to which the confidential supporting informati on relates or related; or 
 
(ii)  if that disclosure or use is, in the opinion of the licensing authority, necessary to 
protect the health or safety of members of the public; 
 
 (b)  disclose that confidential supporting information to —  
(i)  a Government department or statutory body for the purposes of the Government department or statutory body; or 
 
(ii)  any adviser engaged by the licensing authority to advise on any aspect of the medicinal product to which the confidentia l supporting information relates or is 
related, 
  IP/N/1/SGP/U/2/Add.1 
 Page 21 
 
 
  if, in the opinion of the licensing authority, the Government department, statutory body or 
adviser, as the case may be, will take reasona ble steps to ensure the confidential supporting 
information is kept confidential; or 
  (c)  disclose that confidential supporting information to any one or more of the following: 
 
  (i)  the World Health Organisation;    (ii)  the Food and Agriculture Organisation;  
  (iii)  any regulatory agency of a WTO Country; 
   (iv)  any advisory committee established under section 73;  
(v)  any person or organisation, or a person or organisation within a class or classes of 
persons or organisations, a pproved by regulations made under this Act, if the 
disclosure is in accordance with such conditions as may be specified in the 
regulations. 
 (2) The power to grant consent under subsection (1)(a )(i) may be exercised by a person other than the 
applicant referred to in that subsection if — 
 
 (a)  that applicant —  
(i)  has notified the licensing authority in writing that that other person may grant that consent; and 
 
(ii)  has not notified the licensing authority in writing that that person's authority to grant that consent has been withdrawn; or 
 
(b)  that applicant's rights in respect of the relevant confidential su pporting information have 
been transferred to that person and the applican t or that other person has notified the licensing 
authority in writing of the transfer. 
 (3) For the purposes of this section, “WTO Country” means a country that is a party to the Agreement 
establishing the World Trade Organisation adopted at Marrakesh on 15th April 1994.    Licensing authority may publish information on applications. 
19C. —(1)   Notwithstanding any restriction on the di sclosure of information imposed by any written 
law or rule of law, the licensing authority may fro m time to time publish, for the information of the 
public and in the manner determined by it, such particulars of applications for licences which it 
received as it may determine.    
(2)   The particulars referred to in subsection (1) excludes — 
  (a)  any trade secret; and  
(b)  any information that has commercial value that would be, or would be likely to be, 
diminished by disclosure. 
 IP/N/1/SGP/U/2/Add.1 
Page 22  
 
  No product licence to be granted on basis of previous grant. 
19D. —(1)   Where — 
 
(a)  information has been provided by an app licant for a product li cence to the licensing 
authority relating to the safety or efficacy of a medicinal product in support of such 
application; and 
 
(b)  a product licence has been granted in respect of that medicinal product (referred to in this section as the earlier licence), 
 
the licensing authority may not, for a period of 5 years from the date of such grant, grant a product 
licence to another person in respect of that or a si milar medicinal product on the basis of the grant of 
the earlier licence unless the holder of the earlier licen ce has given his consent to the grant on that 
basis.    
(2)   This section applies where the earlier licence is granted — 
  (a)  on or after the date of commencemen t of the Medicines (Amendment) Act 2004; or 
 
(b)  at any time between the date that is be fore the date of commencement but no earlier than 
5 years before that date, and that date. 
 
Offences under this Part. 
20.—(1) Subject to section 21, any person who contrave nes any of the provisions of sections 5 and 6, 
or who is in possession of any medicinal product for the purpose of selling, supplying or exporting it 
in contravention of any of those sections , shall be guilty of an offence.   
 
(2) Where any medicinal product is imported in cont ravention of section 5, an y person who, otherwise 
than for the purpose of performing or exercising a duty or power imposed or conferred by or under 
this Act, or any other written law, is in po ssession of the product knowing or having reasonable cause 
to suspect that it was so imported sh all be guilty of an offence.   
 
(3)   Any person who, when making an app lication under section 11 or a declaration under 
section 12A (2) or giving any information he is re quired to give under section 19, makes a statement 
which he knows or has reason to believe is false in a ma terial particular, shall be guilty of an offence.   
 (3A)   Any person who, when required to furnish to the licensing authority any evidence or document 
under section 12A (3), furnishes to the licensing aut hority any thing which he knows or has reason to 
believe is forged or altered, sh all be guilty of an offence.   
 (4) Any person who without reasonable excuse fails to  comply with a requirement imposed on him by 
a notice under section 19 (2) shall be guilty of an offence.    
(5) Any person guilty of an offence under subsection (1), (2), (3) or (3A) shall be liable on conviction 
to a fine not exceeding $5,000 or to imprisonment fo r a term not exceeding 2 years or to both.   
 (6) Any person guilty of an offence under subsection (4) shall be liable on conviction to a fine not 
exceeding $2,000.   
 
Special defences under section 20. 
21.—(1) Where the holder of a product licence is char ged with an offence under section 20 in respect 
of any medicinal product which has been manufactur ed or assembled to his order by another person  IP/N/1/SGP/U/2/Add.1 
 Page 23 
 
 
  and has been so manufactured or assembled as not to comply with the provisions of that licence which 
are applicable to it, it shall be a defence for him to prove —   (a) that he had communicated those pr ovisions to that other person; and 
 
(b) that he did not know, and could not by th e exercise of reasonable care have discovered, 
that those provisions had not been complied with. 
 (2) Where the holder of a manufacturer’s licence is charged with an offence under section 20 in respect of any medicinal products which have been manufactured or assembled by him, in 
circumstances where he is not the holder of a pr oduct licence which is applicable to those products, 
but the products were manufactured or assembled to the order of another person, it shall be a defence 
for him to prove that he believed, and had reasonable grounds for believing —  
(a) that the other person in question was the holder of a product licence applicable to those 
products; and 
  (b) that the products were manufactured or assembled in accordance with that product licence. 
 
Certificates for exporters of medicinal products. 
22.—On the application of any person who proposes to  export medicinal products of any description, 
the licensing authority may issue to such person a cer tificate containing any such statement relating to 
medicinal products of that description as the licen sing authority may consider appropriate having 
regard —  
(a) to any requirements (whether having the for ce of law or not) which have effect in the 
country to which the products are to be exported; and 
 
(b) to the provisions of this Act and to any licence granted or other thing done by virtue of 
this Act.   
PART III 
 
FURTHER PROVISIONS RELATI NG TO DEALINGS WITH 
MEDICINAL PRODUCTS 
 
General sale list. 
23*.—(1) The Minister may by order specify descrip tions or classes of medicinal products, as being 
products which in his opinion can with reasonable saf ety be sold or supplied otherwise than by or 
under the supervision of a pharmacist.   
* wef 3.5.93 vide S156/93   
 (2) In this Act any reference to a medicinal product on a general sale list is a reference to a medicinal 
product of a description, or falling within a class, sp ecified in an order under this section which is for 
the time being in force.    Sale or supply of medicinal pro ducts not on general sale list. 
24*.—Subject to any exemption conferred by or under this Part, on and after such day as the Minister 
may appoint for the commencement of this Part (r eferred to in this Part as the appointed day) no IP/N/1/SGP/U/2/Add.1 
Page 24  
 
  person shall sell by retail or supply in circum stances corresponding to retail sale any medicinal 
product which is not a medicinal product on a general sale list, unless —   (a) the product is sold or supplied on pr emises which are a registered pharmacy; and 
 
 (b) that person is or acts under th e personal supervision of a pharmacist. 
 * wef 3.5.93 vide S156/93  
Sale or supply of medicinal pr oducts on general sale list. 
25*.—Nothing in this Act shall prevent any person from selling by retail or supplying in 
circumstances corresponding to retail sale any medicinal product on a ge neral sale list subject to such 
conditions as may be prescribed for the purposes of this section.   * wef 3.5.93 vide S156/93 
 
Prohibition of sale of medicinal products from automatic machines. 
26*.—On and after the appointed day a medicinal product shall not be sold by means of an automatic 
machine unless it is a medicinal product in the auto matic machine section of  a general sale list and 
complies with such conditions as may be prescribed.   
* wef 3.5.93 vide S156/93 
 
Exemptions for doctors, dentists and veterinary  surgeons and in respect of herbal remedies. 
27*.—(1) The restrictions imposed by section 24 sh all not apply to the supply of a medicinal 
product — 
 
 (a) by a doctor or dentist to his patient; or  
(b) by a hospital where the product is supplied for the purpose of being administered in accordance with the directions of a doctor or a dentist. 
 
* wef 3.5.93 vide S156/93   
 (2) The restrictions imposed by that section shall not apply to the supply of a medicinal product by a veterinary surgeon for administration by him or under his direction to an animal under his care.    
(3) The restrictions imposed by that section shall not  apply to anything done at  premises of which the 
person carrying on the business in question is the o ccupier and which he is able to close so as to 
exclude the public, and which consists of the sal e or the supply in circumstances corresponding to 
retail sale of a herbal remedy where the processes to which the plant or plants are subjected consist of 
drying, crushing or comminuting, with or without diluting with water, but not any other process.   
 Power to extend or modify exemptions. 
28*.—(1) The Minister may by order provide that section 24 shall have effect subject to such 
exemptions (other than those for the time being having effect by virtue of section 27) as may be 
specified in the order.   
* wef 3.5.93 vide S156/93   
 (2) Any exemption conferred by an order under s ubsection (1) may be conferred subject to such 
conditions or limitations as may be specified in the order.     IP/N/1/SGP/U/2/Add.1 
 Page 25 
 
 
  (3) The Minister may by order provide that section 27 shall have effect subject to such exceptions or 
modifications as may be specified in the order.    
Medicinal products on prescription only. 
29*.—(1) The Minister may by order specify descriptions or classes of medicinal products for the 
purposes of this section; and, in relation to any d escription or class so specified, the order shall state 
which of the following are to be appropriate practitioners for the purposes of this section: 
  (a) doctors;  
 (b) dentists; and 
  (c) veterinary surgeons.  * wef 3.5.93 vide S156/93   
 
(2) Subject to the following provisions of this section —  
(a) no person shall sell by retail, or supply in  circumstances corresponding to retail sale, a 
medicinal product of a description, or falling with in a class, specified in an order under this 
section except in accordance with a prescription given by an appropriate practitioner; and 
 
(b) no person shall administer (otherwise than  to himself) any such medicinal product unless 
he is an appropriate practitioner or a person ac ting in accordance with the directions of an 
appropriate practitioner. 
 
(3) An order made by the Minister for the purposes of this section may provide — 
 
(a) that subsection (2) (a) or (b), or subsection (2 ) (a) and (b), shall have effect subject to such 
exemptions as may be specified in the order; or 
 
(b) that, for the purpose of subsection (2) (a), a medicinal product shall not be taken to be 
supplied in accordance with a prescription give n by an appropriate practitioner unless such 
conditions as are prescribed by the order are fulfilled. 
 (4) Any exemption conferred by an order in acco rdance with subsection (3) (a) may be conferred 
subject to such conditions or limitations as may be specified in the order.   
 
Prohibition of sale, supply or importation of medi cinal products of specified description or of 
animal feeding stuffs incorporating such products. 
30.—(1) The Minister may, where it appears to him to be necessary to do so in the interests of safety, 
by order —  
(a) prohibit the sale or supply, or the importation,  of medicinal products of any description, or 
falling within any class, specified in the order; and 
 
(b) prohibit the sale or supply, or the importation, of animal feeding stuffs in which medicinal products of any description, or falling within any class, specified in the order have been 
incorporated. 
 (2) A prohibition imposed by order under this sectio n may be a total prohibition or may be imposed 
subject to such exceptions as may be specified in the order.    IP/N/1/SGP/U/2/Add.1 
Page 26  
 
  Adulteration of medicinal products. 
31.—No person shall — 
 
(a) add any substance to, or abstract any subs tance from, a medicinal product so as to affect 
injuriously the composition of the product, with  intent that the product shall be sold or 
supplied in that state; or 
 
(b) sell or supply any medicinal product whose composition has been injuriously affected by the addition or abstraction of any substance. 
 Protection of purchasers of medicinal products. 
32*.—(1) No person shall, to the prejudice of the purchaser, sell any medicinal product which is not 
of the nature or quality demanded by the purchaser.   * wef 3.5.93 vide S156/93   
 
(2) For the purposes of this section the sale of a medicinal product sha ll not be taken to  be otherwise 
than to the prejudice of the purchaser by reason on ly that the purchaser buys the product for the 
purpose of analysis or examination.    (3) Subsection (1) shall not be taken to be c ontravened by reason only that a medicinal product 
contains some extraneous matter, if it is proved th at the presence of that matter was an inevitable 
consequence of the process of manufacture of the product.    (4) Subsection (1) shall not be take n to be contravened by reason only that a substance has been added 
to, or abstracted from, the medicinal product, if it is proved that — 
 
(a) the addition or abstraction was not carried out fraudulently, and did not injuriously affect 
the composition of the product; and 
 
(b) the product was sold having attached to it, or to a container or package in which it was 
sold, a conspicuous notice of adequate size a nd legibly printed, specifying the substance 
added or abstracted. 
 (5) Where a medicinal product is sold or supplied in pursuance of a prescription given by a practitioner, subsections (1) to (4 ) shall have effect as if — 
 
(a) in those provisions any reference to sale included a reference to supply and (except as 
provided by paragraph (b)) any reference to th e purchaser included a reference to the person 
for whom the product was prescribed by the practitioner; and 
 
(b) in subsection (1), for the words “demande d by the purchaser”, there were substituted the 
words “specified in the prescription”. 
 
Compliance with standards specified in  monographs in certain publications. 
33*.—(1) No person shall — 
 
(a) sell a medicinal product which has been de manded by the purchaser by or by express 
reference to a particular name; or 
 
(b) sell or supply a medicinal product in pursu ance of a prescription given by a practitioner in 
which the product required is described by or by express reference to a particular name, 
  IP/N/1/SGP/U/2/Add.1 
 Page 27 
 
 
  if that name is a name at the head of the rele vant monograph and the product does not comply with 
the standard specified in that monograph.   * wef 3.5.93 vide S156/93    
(2) No person shall sell or supply a medicinal product by or by express reference to a particular name, 
if that name is a name at the head of the relevant monograph unless the product complies with the 
standard specified in that monograph.    (3) Where a medicinal product is sold or supplied in  the circumstances specified in subsection (1) or 
(2), and the name in question is the name, not of th e product itself, but of an active ingredient of the 
product, then for the purposes of the subsection in question the product shall be taken not to comply 
with the standard specified in the relevant monograph if, in so far as it consists of that ingredient, it 
does not comply with the st andard so specified.   
 
(4) In this section “publication” means one of the following, that is to say, the British Pharmacopoeia, 
the European Pharmacopoeia or the United States Pharmacopoeia, the British Pharmaceutical Codex 
and the British Veterinary Codex; a nd “the relevant monograph”, in relation to the sale or supply of a 
medicinal product by or by express reference to a particular name —  
(a) if, together with that name, there was specified a particular edition of a particular 
publication, means the monograph headed by that name  in that edition of that publication or if 
there is no such monograph in that edition, me ans the appropriate current monograph headed 
by that name; 
 
(b) if, together with that name, there was specified a particular publication, but not a 
particular edition of that publication, means the monograph headed by that name in the 
current edition of that publication, or, if ther e is no such monograph in that edition, means the 
appropriate current monograph headed by that name, or, in default of such a monograph, 
means the monograph headed by th at name in the latest editi on of the specified publication 
which contained a monograph so headed; 
 
(c) if no publication was specified together w ith that name, means the appropriate current 
monograph, 
 and “current” means current at the time when the medici nal product in question is sold or supplied.   
 
(5) In this section 
  "the appropriate current monograph" , in relation to a particular name, means —   
 
(a) the monograph headed by that name  in the current edition of the British 
Pharmacopoeia, the European Pharmacopoeia or the United States Pharmacopoeia; or 
 
(b) if there is no such monograph, then the monograph headed by that name in the current edition of the British Pharmaceutical Codex or the British Veterinary Codex . 
 (6) For the purposes of this section an edition of a publication — 
 
(a) if it is current edition of that publication, shall be taken as it is for the time being in force 
(that is to say, together with any amendments , additions and deletions  made to it up to the 
time referred to in subsection (4)); or 
 IP/N/1/SGP/U/2/Add.1 
Page 28  
 
  (b) if it is an edition previous to the current ed ition of that publication, shall be taken as it was 
immediately before the time when it was s uperseded by a subsequent edition of that 
publication (that is to say, together with any amendments, additions a nd deletions made to it 
up to that time), 
 
and any monograph in an edition of a publication sh all be construed in accordance with any general 
monograph or notice or any appendix, note or other e xplanatory material which is contained in that 
edition and is applicable to that monograph, and an y reference in this section to compliance with the 
standard specified in a monograph sh all be construed accordingly.   
 
(7) The Minister may by order amend subsections (4), (5) and (6).   
 
Further powers to regulate dealings with medicinal products. 
34.—(1) The Minister may by regulations prescrib e such requirements as he may consider necessary 
or expedient with respect to any of the following matters: 
 
(a) the manner in which, or persons under w hose supervision, medicinal products may be 
prepared or may be dispensed; 
 
(b) the amount of space to be provided in any premises for persons preparing or dispensing medicinal products, the separation of any such space from the remainder of the premises, and 
the facilities to be provided in any premises for such persons; 
 
(c) the amount of space to be provided in any premises for the sale or supply of medicinal 
products; 
 
(d) the accommodation (including the amount of space) to be provided in any premises for 
members of the public to whom medicinal pr oducts are sold or supplied or for whom 
medicinal products are being prepared or assembled; 
  (e) the amount of space to be provided in any premises for the storage of medicinal products; 
 
 (f) the safekeeping of medicinal products; 
  (g) the disposal of medicinal products which have become unusable or otherwise unwanted; 
  (h) precautions to be observed before me dicinal products are sold or supplied; 
 
 (i) the keeping of records relating to the sale or supply of medicinal products;   (j) the supply of medicinal products distributed as samples;  
(k) sanitation, cleanliness, temperature, humidity or other factors relating to the risks of 
deterioration or contamination in connection w ith the manufacture, storage, transportation, 
sale or supply of medicinal products; 
 
(l) the construction, location and use of au tomatic machines for the sale of medicinal 
products. 
  IP/N/1/SGP/U/2/Add.1 
 Page 29 
 
 
  (2) Without prejudice to the generality of subsecti on (1), such regulations may prescribe requirements 
in respect of —  
(a) the construction, lay-out, drainage, equipm ent, maintenance, ve ntilation, lighting and 
water supply of premises at or from which medicinal products are manufactured, stored, 
transported, sold or supplied; 
  (b) the disposal of refuse at or from any such premises; and   (c) any apparatus, equipment, furnishings or utensils used at any such premises. 
 
Offences under this Part. 
35.—(1) Any person who contravenes section 24, 26, 29, 31, 32 or 33 or who contravenes any order 
made under section 30, shall be guilty of an offence.    
(2) Where a medicinal product is sold, supplied or imported in contravention of an order made under 
section 30, any person who, otherwise than for th e purpose of performing or exercising a duty or 
power imposed or conferred by or under this Ac t or any other written law,  is in possession of the 
medicinal product, knowing or having reasonable cau se to suspect that it was sold, supplied or 
imported in contravention of the order,  shall be guilty of an offence.   
 
(3) Any person guilty of an offence under subsection (1) or (2) shall be liable on conviction to a fine 
not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both.    (4) Any person who contravenes any conditions prescribed for the purpose of section 25 shall be 
guilty of an offence and shall be liable on conviction to a fine not exceeding $2,000.   
 
 
PART IV 
 
PHARMACIES 
 
General provisions. 
36.—(1) The Minister may by regulations prescribe the conditions and requirements to be complied 
with by a person carrying on a retail pharmacy business.   
 (2) In this Part  
"the appointed day" means such day as the Minister may appoint for the coming into operation of this Part. 
 
Registration of premises. 
37.—(1) It shall be the duty of the licensing aut hority to keep a register of pharmacies for the 
purposes of this section (referred to in this Part as the register) and, subject to the following provisions of this section, on payment of the prescribed fee to enter in the register any premises in respect of 
which an application is made under this section.   
 (2) Any application for the registration of premises under this section shall be made in the prescribed 
manner and shall specify the premises to which the application relates and shall contain such other 
particulars as may be prescribed.    IP/N/1/SGP/U/2/Add.1 
Page 30  
 
  (3) If it appears to the licensing authority that in a material respect the premises do not comply with 
the requirements of the regulations made under section 34 which are for the time being in force or that 
the applicant is not a suitable person to conduct a retail pharmacy business, he may refuse to register 
the premises.    
(4) The applicant may appeal against the decision of the licensing authority to the Minister whose 
decision shall be final.    
Supplementary provisions as to registration of premises. 
38.—(1) Where any premises have been entered in  the register, then, in respect to each year 
subsequent to the year in which the premises were so  entered, a further fee (referred to in this section 
as a retention fee) of the prescribed amount shall be payable by the person carrying on a retail 
pharmacy business at those premises.    (2) If the person carrying on a retail pharmacy business at  any premises entered in the register fails to 
pay a retention fee in respect of those premises within one month from the date on which the fee is 
payable, the licensing authority may remove the prem ises from the register; but if, before the end of 
the year in respect of which the retention fee is paya ble or such longer period as in any particular case 
the licensing authority may allow, the person carry ing on the business pays to the licensing authority 
the retention fee in respect of that year, together with such additional sum (if any) by way of penalty 
as may be prescribed, the licensing authority may restor e the premises to the register with effect from 
such date as he thinks fit.   
 (3) Where a change occurs in the ownership of a retail pharmacy business carried on at any premises 
registered under this Act, the registration of the pr emises shall become void at the end of 6 months 
from the date on which the change occurs.   
 
(4) Where the registration of any premises under th is Act in respect of a business becomes void by 
virtue of subsection (3), an application for the premis es to be restored to the register may be made by 
the person who, in consequence of the change of  ownership has become the owner of the business; 
and where such an application is made the licensing au thority may restore the premises to the register.   
 
(5) A certificate signed by the licensing authority and stating that, on a specified date, specified 
premises were, or were not, entered in the register  shall be admissible in an y proceedings as evidence 
that those premises were, or were not, en tered in the register on that date.   
 
Restrictions on use of titles, descriptions and emblems. 
39.—(1) On and after the appointed day — 
 
(a) no person shall, in connection with the reta il sale of any medicinal products or the supply 
of any medicinal products in circumstances co rresponding to retail sale, use the description 
“pharmacy” or “dispensary” except in respect of  a registered pharmacy or in respect of the 
pharmaceutical department of a hospital by or under the supervision of a pharmacist; 
 
(b) no person shall take or use the following  titles, that is to say, chemist and druggist, 
druggist, dispensing chemist, dispensing druggis t, pharmaceutical chemist, pharmaceutist and 
pharmacist, in connection with the retail sale of  any medicinal products, or the supply of any 
medicinal products in circumstances correspondi ng to retail sale, at any premises unless those 
premises are a registered pharmacy or the pha rmaceutical department of a hospital by or 
under the supervision of a pharmacist; and 
 
(c) no person shall, in connec tion with any premises used for the purpose of the sale of 
medicinal products, use any title, description or emblem likely to suggest —  IP/N/1/SGP/U/2/Add.1 
 Page 31 
 
 
   
(i) that he possesses any qualification whic h he does not possess with respect to the 
sale, manufacture or assembly of medicinal products; or 
 
(ii) that any person employed in the premises possesses any such qualification which 
that person does not possess. 
 (2) Subsection (1) shall not apply to the use of th e word “dispensary” by a doctor or veterinary 
surgeon in connection with the practice of his profession.    Minister may modify restrictions under section 39. 
40.—The Minister may by order modify any of  the restrictions imposed by section 39. 
 
Power for licensing authority to disqua lify and direct removal from register. 
41.—(1) Where a person carries on a retail pharmacy business and that person is convicted of an 
offence under any relevant written law, the licensi ng authority may remove from the register all 
premises entered in the register as being premises at which that person carries on a retail pharmacy business.    (2) In this section  
"relevant written law"  means this Act, th e Poisons Act, the Pharmacists Registration 
Act 2007, the Misuse of Drugs Act, and any su bsidiary legislation made thereunder.  
 
Cap. 234. Cap. 185. 
 
Appeal relating to disqualification. 
42.—Any person aggrieved by the decision of the licensing authority under section 41 may appeal to 
the Minister whose decision shall be final.  
Offences under this Part. 
43.—Any person who contravenes section 39 shall be guilty of an offence and shall be liable on 
conviction to a fine not exceeding $2,000.   
PART V 
 
CONTAINERS, PACKAGES AND ID ENTIFICATION OF MEDICINAL 
PRODUCTS 
 
Labelling and marking of containers and packages. 
44.—(1) The Minister may by regulations impose such requirements as he considers necessary or 
expedient with respect to any of the following matters:   (a) the labelling of containers of medicinal products;   (b) the labelling of packages of medicinal products; 
 
 (c) the display of distinctive marks on c ontainers and packages of medicinal products. 
 IP/N/1/SGP/U/2/Add.1 
Page 32  
 
  (2) No person shall sell or supply any medicinal pr oduct in such circumstances as to contravene any 
requirements imposed by such regulations.    (3) In so far as any such requirements relate to th e labelling or marking of containers of medicinal 
products, a person who sells or supplies a medicinal product to which the requirements are applicable 
without it being enclosed in a container shall, excep t in so far as the regulations otherwise provide, be 
taken to contravene those requirements as if he ha d sold or supplied it in a container not complying 
with those requirements.    (4) Without prejudice to subsections (1), (2) and (3), no person shall sell or supply a medicinal 
product of any description in a container or package which is labelled or marked in such a way that 
the container or package —   (a) falsely describes the product; or  
(b) is likely to mislead as to the nature or qualit y of the product or as to the uses or effects of 
medicinal products of that description. 
 
Leaflets. 
45.—(1) The Minister may by regulations impose such requirements as he considers necessary or 
expedient with respect to leaflets relating to medici nal products which are supplied, or are intended to 
be supplied, with the products, whet her by being enclosed in containe rs or packages of the products or 
otherwise.    (2) No person shall supply with any medicinal pr oducts, or have in his possession for the purpose of 
so supplying, a leaflet which contravenes any re quirements imposed by such regulations.   
 
(3) Without prejudice to subsections (1) and (2), no person shall supply with a medicinal product of 
any description, or have in his possession for the purpose of so supplyin g, a leaflet which — 
  (a) falsely describes the product; or  
(b) is likely to mislead as to the nature or qualit y of the product or as to the uses or effects of 
medicinal products of that description. 
 
Requirements as to containers. 
46.—(1) The Minister may by regulations prohibit th e sale or supply of medicinal products otherwise 
than in containers which comply with such requirements as the Minister considers necessary or 
expedient and in particular may require such containe rs to be of such strength, to be made of such 
materials and to be of such shapes or patterns, as may be prescribed.    (2) No person shall sell or supply, or have in his possession for the purpose of sale or supply, any 
medicinal product in such circumstances as to contravene any requirements imposed by such 
regulations.   
 
Distinctive colours, shapes and markings of medicinal products. 
47.—(1) The Minister may by regulations impose such requirements as he considers necessary or 
expedient with respect to any one or more of the following matters: 
 
 (a) the colour of medicinal products;   (b) the shape of medicinal products; and   IP/N/1/SGP/U/2/Add.1 
 Page 33 
 
 
   (c) the distinctive marks to be displayed on medicinal products. 
 (2) Such regulations may provide that medicinal pr oducts of any such description, or falling within 
any such class, as may be specified in the regulations shall not, except in such circumstances, if any, 
as may be so specified, be of any such colour or shape, or display any such mark, as may be so 
specified.   
 (3) No person shall sell or supply, or have in his possession for the purpose of sale or supply, any 
medicinal product which contravenes any requi rements imposed by such regulations.   
 Offences under this Part a nd supplementary provisions. 
48.—(1) Any person who contravenes section 44 (2), (3) or (4), 45 (2) or (3), 46 (2) or 47 (3) shall be 
guilty of an offence and shall be liable on co nviction to a fine not exceeding $5,000 or to 
imprisonment for a term not exceeding 2 years or to both.    
 
PART VI 
 
PROMOTION OF SALES OF MEDICINAL PRODUCTS AND 
MEDICAL ADVERTISEMENTS 
 
Scope of this Part. 
49.—(1) Subject to the following provisions of this section, in this Part “advertisement” includes 
every form of advertising, whether in a publication, or by the display of any notice or signboard, or by 
means of any catalogue, price list, letter (whether circ ular or addressed to a particular person) or other 
documents, or by words inscribed on any article , or by the exhibition of a photograph or a 
cinematograph film, or by way of sound recording, sound broadcasting or television, or in any other 
way, and any reference to the issue of an a dvertisement shall be construed accordingly.   
 (2) Notwithstanding anything in subsection (1), in this Part “advertisement”  does not include spoken 
words except —  
(a) words forming part of a sound recording or embodied in a sound-track associated with a 
cinematograph film; and 
 
(b) words broadcast by way of sound broadcasti ng or television or transmitted to subscribers 
to a diffusion service. 
 
(3) Except as provided by section 52, for the purposes of this Part neither of the following shall be 
taken to constitute the issue of an advertisement:   (a) the sale or supply of a medicinal product in a labelled container or package; 
 
(b) the supply, with a medicinal product of any description, of a leaflet relating solely to medicinal products of that description. 
 (4) In this Part —  
"medical advertisement"  means an advertisem ent relating or likely to cause any person to 
believe that it relates to any medicinal produc t or any device, instrument, apparatus or 
contrivance used or represented to  be used for a medicinal purpose; IP/N/1/SGP/U/2/Add.1 
Page 34  
 
   
"representation"  means any statement or unde rtaking (whether constituting a condition or a 
warranty or not) which consists of spoke n words other than words falling within 
subsection (2) (a) or (b), and any reference to making a representation shall be construed 
accordingly. 
 
False or misleading advertisements and representations. 
50.—(1) Subject to the following provisions of this section, any person who issues or causes another 
person to issue a false or misleading advertisement relating to medicinal prod ucts of any description 
shall be guilty of an offence.   
 
(2) Where a licence under Part II is in force which is applicable to medicinal products of a particular 
description, and, in accordance with the provisions  of the licence, the purposes for which medicinal 
products of that description may be recommended to be used are limited to those specified in the 
licence, then, subject to the following provisions of this section, any person who issues or causes 
another person to issue an adver tisement relating to medicinal products of that description which 
consists of or includes unauthorised recommenda tions shall be guilty of an offence.   
 (3) Subject to the following provisions of this sect ion, any person who makes a false or misleading 
representation relating to a medicinal product in c onnection with the sale of that product shall be 
guilty of an offence; and any person who makes a false or misleading representation relating to 
medicinal products of a particular description — 
 
(a) to a practitioner for the purpose of induci ng him to prescribe or supply medicinal products 
of that description; 
 
(b) to a patient or client of a practitioner fo r the purpose of inducing him to request the 
practitioner to prescribe medicinal pr oducts of that description; or 
 
(c) to a person for the purpose of inducing him to purchase medicinal products of that 
description from a person selling them by retail, 
 
shall be guilty of an offence.   
 (4) Where in the circumstances specifi ed in subsection (2) any person — 
 
(a) in connection with the sale of a medicinal product of the description in question, makes a 
representation relating to the product which consists of or includes unauthorised 
recommendations; or 
 
(b) for any such purpose specified in subsecti on (3) (a), (b) and (c) makes a representation 
relating to medicinal products of that descrip tion which consists of or includes unauthorised 
recommendations, 
 
that person, subject to the following provisions of this section, shall be guilty of an offence.   
 (5) Where a person is charged with an offence under this section, it shall be a defence for him to 
prove — 
 
(a) where the offence charged is under subsection (1) or (3), that he did not know, and could 
not with reasonable diligence have discovered, that the advertisement or representation was 
false or misleading; 
  IP/N/1/SGP/U/2/Add.1 
 Page 35 
 
 
  (b) where the offence charged is under subsection (2) or (4), that he did not know, and could 
not with reasonable diligence have discovered,  that the recommendations made by the 
advertisement or representation we re unauthorised recommendations. 
 (6) For the purposes of this section an advertisement (whether it contains an accurate statement of the 
composition of medicinal products of the description in  question or not) shall be taken to be false or 
misleading if —   (a) it falsely describes the description of medicinal products to which it relates; or  
(b) it is likely to mislead as to the nature or quality of medicinal products of that description 
or as to their uses or effects, 
 and any reference in this section to a false or misleading representation shall be construed in a 
corresponding way.   
 
(7) Any person guilty of an offence under this sec tion shall be liable on conviction to a fine not 
exceeding $5,000 or to imprisonment of a term not exceeding 2 years or to both.    (8) In this section “unauthorised recommendations”,  in relation to the circumstances specified in 
subsection (2), means recommendations whereby medi cinal products of a description to which the 
licence in question is applicable are recommended to be used for purposes other that those specified in 
the licence.    
Prohibition of certain medical advertisements. 
51.—(1) No person shall publish or cause to be published — 
 
(a) any medical advertisement which directly or indirectly claims, indicates or suggest that the article advertised will prevent, alleviate or cu re any disease or condition specified in the First 
Schedule; or 
 
(b) any advertisement referring to any skill or service relating to the treatment of any disease 
or condition affecting the human body. 
 (2) Subsection (1) shall not apply to any advertisemen t which is distributed only to, or is contained in 
a publication intended for circulation mainly among one or more of the following classes of persons: 
 
 (a) practitioners; 
  (b) pharmacists;   (c) nurses and midwives;  
(d) persons undergoing training with a view  to becoming practitioners, pharmacists or nurses 
and midwives. 
 (3) Any person who contravenes subsection (1) shall be guilty of an offence and shall be liable on 
conviction to a fine not exceeding $5,000 or to im prisonment for a term not exceeding 2 years or to 
both.   
 IP/N/1/SGP/U/2/Add.1 
Page 36  
 
  (4) The Minister may by order — 
  (a) amend the First Schedule; and   (b) exempt any advertisement or class of advertisements from subsection (1). 
 
Powers to regulate advertisements and representations. 
52.—(1) The Minister may by regulations prohibit any one or more of the following: 
 
(a) the issue of advertisements relating to medicinal products of a description, or falling 
within a class, specified in the regulations; 
 
(b) the issue of advertisements likely to lead to  the use of any medicinal product, or any other 
substance or article, for the purpose of treating or preventing a disease specified in the regulations or for the purpose of diagnosis of a disease so specified or of ascertaining the 
existence, degree or extent of a physiological condition so specified or of permanently or 
temporarily preventing or otherwise interfering with the normal operation of a physiological function so specified, or for the purpose of ar tificially inducing a cond ition of body or mind 
so specified; 
 
(c) the issue of advertisements likely to lead to  the use of medicinal products of a particular 
description or falling within a particular class sp ecified in the regulations, or the use of any 
other substance or article of a description or  class so specified, for any such purpose as is 
mentioned in paragraph (b); 
 
(d) the issue of advertisements relating to medi cinal products and containing a word or phrase 
specified in the regulations, as being a word or phr ase which, in the opinion of the Minister, is 
likely to mislead the public as to the nature or effects of the products or as to any condition of body or mind in connection with which the products might be used. 
 (2) Without prejudice to subsection (1), the Minister  may by regulations impose such requirements as 
he considers necessary or expedient with respect to any one or more of the following matters: 
 
 (a) the form and content of advertis ements relating to medicinal products; 
 
(b) the obtaining of prior approval from the licensing authority for the issue of any such 
advertisements; 
 
(c) in the case of advertisements by way of cine matograph films or television, the duration for 
which, and the manner in which, any part of su ch an advertisement whic h contains particulars 
of a description specified in the regulations must be exhibited; 
  (d) advertisements and representa tions directed to practitioners, 
 
and any such regulations may proh ibit the use, in relation to me dicinal products of a description 
specified in the regulations, of advertisements  of any particular kind so specified.   
 
Power of licensing authority to require copies of advertisements. 
53.—(1) The licensing authority may serve on any person a notice requiring him, within such time as 
may be specified in the notice, to  furnish to the licensing authority such number of copies as may be 
so specified of any advertisement relating to me dicinal products or to medicinal products of a 
description or falling within a class so specified, wh ich such person has issued, or has caused to be 
issued, within 12 months ending with the date of service of the notice.    IP/N/1/SGP/U/2/Add.1 
 Page 37 
 
 
   
(2) Any person who without reasonable excuse fails to comply with any requirement imposed on him 
by a notice under this section shall be guilty of an o ffence and shall be liable on conviction to a fine 
not exceeding $2,000.    
 
PART VII 
 
MISCELLANEOUS AND SUPP LEMENTARY PROVISIONS 
 
Application of this Act to certain articles and substances. 
54.—(1) The Minister may by order specify any description or class of articles or substances 
appearing to him to be articles or substances wh ich are not medicinal products but are manufactured, 
sold, supplied, imported or exported for use whol ly or partly for a medicinal purpose or for a 
cosmetic, and may by the order direct that, subject to such exceptions and modifications as may be specified in the order, such provisions of this Ac t as may be so specified (including provisions so 
specified which relate to offences or penalties) shall have effect in relation to articles or substances of 
that description or class as those provisions have effect in relation to medicinal products.   
 
(1A)   An order under subsection (1) may —  
(a)  apply to any class or description of chewi ng gum that is intended for use in promoting 
dental health or oral hygiene; and 
 
(b)  require the chewing gum to be sold or supplied by prescription or by or under the 
supervision of a pharmacist. 
 (2) In this section, “cosmetic” means any article in tended to be rubbed, poured, sprinkled or sprayed 
on, or introduced into, or otherwise applied to , the human body or any part thereof for cleansing, 
beautifying, promoting attractiveness or altering the appearance, and includes a deodorant or any 
depilatory substance but do es not include a soap.   
 
Application of this Act to certain other s ubstances which are not medicinal products. 
55.—The Minister may by order specify any substan ce appearing to the Minister to be a substance 
which is not itself a medicinal product but — 
  (a) is used as an ingredient in the manufacture of medicinal products; or  
(b) if used without proper safeguards, is cap able of causing danger to the health of the 
community, or of causing danger to the health of animals generally or of one or more species 
of animals, 
 and direct that, subject to such exceptions and modi fications as may be specified in the order, such 
provisions of this Act as may be so specified (incl uding any provisions so specified which relate to 
offences or penalties) shall have effect in relation to  that substance as those provisions have effect in 
relation to medicinal products. 
 IP/N/1/SGP/U/2/Add.1 
Page 38  
 
  Rights of entry. 
56.—(1) Any person duly authorised in writing by the licensing authority may at any reasonable 
time —  
(a) enter any premises for the purpose of ascertain ing whether there is or has been, on or in 
connection with those premises, any contraventi on of any provisions of this Act or of any 
regulations or orders  made thereunder; 
 
(b) enter any premises generally for the purpo ses of the performance by the authority of his 
functions under this Act or under any regu lations or orders ma de thereunder; or 
 
(c) enter any ship, aircraft, hovercraft or vehi cle for the purpose of ascertaining whether there 
is in the ship, aircraft, hovercraft or vehicle an y substance or article im ported in contravention 
of any provisions of this Act or of any regulations or orders  made thereunder. 
 
(2) Without prejudice to subsection (1), any pers on duly authorised in writing by the licensing 
authority may at any reasonable time enter any prem ises occupied by an applicant for a licence or 
certificate or for renewal thereof under Part II for th e purpose of verifying any statement contained in 
the application for the licence or certificate.    
Power to inspect, take samples and seize goods and documents. 
57.—(1) For the purpose of ascertaining whether there is  or has been a contravention of this Act or 
any regulations or orders made thereunder, any person duly authorised in writing by the licensing 
authority may inspect —   (a) any substance or article appeari ng to him to be a medicinal product; 
 
(b) any article appearing to him to be a containe r or package used or intended to be used to 
contain any medicinal product or to be a label or leaflet used or intended to be used in 
connection with a medicinal product; or 
 
(c) any plant or equipment appearing to him to be used or intended to be used in connection 
with the manufacture or assembly of medici nal products, and any process of manufacture or 
assembly of any medicinal products and the mean s employed, at any stage in the processes of 
manufacture or assembly, for testing the material s after they have been subject to those 
processes. 
 
(2) Where for the purpose specified  in subsection (1) a person au thorised as mentioned in that 
subsection requires a sample of any substan ce or article appearing to him to be — 
  (a) a medicinal product sold or supplied or  intended to be sold or supplied; or 
 
(b) a substance or article used or intended to be used in the manufacture of a medicinal 
product, 
 he may take a sample of that substance or article.    (3) For the purpose specifi ed in subsection (1), any person author ised as mentioned in that subsection 
may — 
 
(a) require any person carrying on a business whic h consists of or includes the manufacture, 
assembly, sale or supply of medicinal products, and any person employed in connection with  IP/N/1/SGP/U/2/Add.1 
 Page 39 
 
 
  such a business, to produce any books or documen ts relating to the business which are in his 
possession or under his control; and 
 
(b) take copies of, or of any entry in, any book or document produced in pursuance of paragraph (a). 
 
(4) Any person so authorised may seize and detain any substance or article which he has reasonable 
cause to believe to be a substance or article in rela tion to which, or by means of which, an offence 
under this Act is being or has been committed, an d any document which he has reasonable cause to 
believe to be a document which may be required as evidence in proceedings under this Act.   
 
(5) Any person so authorised may, so far as is  reasonably necessary in order to secure that the 
provisions of this Act and any re gulations or orders made thereunder are duly observed, require any 
person having authority to do so to break ope n any container or package or open any vending 
machine, or to permit him to do so.   
 
(6) Where a person so authorised seizes any subs tance or article (including any document) under 
subsection (4), he shall inform the person from whom  it is seized, and, in the case of anything seized 
from a vending machine, the person whose name and a ddress are stated on the machine as being those 
of the owner of the machine, or, if no name and a ddress are so stated, the occupier of the premises on 
which the machine stands or to which it is affixed.   
 
(7) The Minister may by regulations prescribe the procedure for the sampling of articles and 
substances seized under this section.    
Supplementary provisions as to rights of entry and related rights. 
58.—(1) Any person entering any property (that is to say , any premises, ship, aircraft, vehicle, stall or 
place) by virtue of section 56 may take with hi m such other persons and such equipment as may 
appear to him to be necessary.    (2) Any person who —  
(a) wilfully obstructs a person acting in pursuance of this Act and duly authorised so to act by 
the licensing authority; or 
 
(b) wilfully fails to comply with any requireme nt properly made to him by a person so acting 
under section 57; or 
 
(c) without reasonable cause fails to give to  a person so acting any other assistance or 
information which that person may reasonably require of him for the purpose of the performance of his functions under this Act, 
 shall be guilty of an offence a nd shall be liable on conviction to a fine not exceeding $2,000.   
 
(3) If a person, in giving any such informati on as mentioned in subsection (2) (c), makes any 
statement which he knows to be false, he shall be guilty of an offence and shall be liable on 
conviction to a fine not exceeding $5,000 or to im prisonment for a term not exceeding 2 years or to 
both.   
 
Seizure or detention of goods subject to prohibition or restriction. 
59.—(1) Any imported goods shall be deemed to be im ported contrary to a prohibition or restriction 
for the time being in force with respect to them if —  IP/N/1/SGP/U/2/Add.1 
Page 40  
 
  (a) they are medicinal products or medicinal s ubstances of any description or falling within a 
class specified in an order made by the Mi nister for the purposes of this section; and 
  (b) they are imported in such circumstances as are specified in that order.  
(2) Any exported goods shall be deem ed to be exported contrary to a prohibition or restriction for the 
time being in force with respect to them if —  
(a) they are medicinal products or medicinal s ubstances of any description or falling within a 
class specified in an order made by the Mi nister for the purposes of this section; and 
 
 (b) they are exported in such circumstances as are specified in that order.  (3) An officer of customs or police officer may sei ze and detain any goods s ubject to a prohibition or 
restriction imposed by an order made under this section.   
 
Forfeiture of goods seized. 
60.—(1) Whenever any goods are seized under this Act,  the seizing officer shall forthwith give notice 
in writing of the seizure to the owner of the goods, if known, either by delivering the notice to him 
personally or by post at his place of abode if known:   
Provided that the notice shall not be required to be given where the seizure is made in the presence of 
the offender or the owner or his agent, or in the case of a ship or aircraft, in the presence of the master 
or captain thereof.    (2) An order for the forfeiture of any goods shall be made if it is proved to th e satisfaction of a court 
that an offence under this Act h as been committed and that the goods  were the subject matter of or 
was used in the commission of th e offence notwithstanding that no person may have been convicted 
of that offence.    (3) If there is no prosecution with regard to an y goods seized under this Act the goods shall be 
deemed to be forfeited at the expiration of one month from the date of the seizure thereof unless a 
claim thereto has been made before that da te in such manner as may be prescribed.   
 
Disposal of goods forfeited. 
61.—(1)   All goods which are forfeited under this Ac t shall be disposed of in such manner as the 
licensing authority thinks fit.   
 
(2)   The licensing authority may, in his discre tion and after any proceedings under this Act are 
concluded, entertain and give effect to any claim to  or in respect of goods which have been forfeited 
under this Act.    
Restrictions on disclosure of information. 
62.—(1) If any person disclo ses to any other person — 
 
(a) any information with respect to any manuf acturing process or trade secret obtained by him 
in premises which he has entered by virtue of section 56; or 
 
 (b) any information obtained by or furnished to him in pursuance of this Act, 
 he shall, unless the disclosure was made in the perfo rmance of his duty, be guilty of an offence.   
  IP/N/1/SGP/U/2/Add.1 
 Page 41 
 
 
  (2) Any person guilty of an offence under this sec tion shall be liable on conviction to a fine not 
exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both.    
Protection for officers. 
63.—No person shall be personally liable in respect  of any act done by him in the execution or 
purported execution of this Act and within the scope of  his employment if he did it in the honest belief 
that his duty under this Act required or entitled him to do it.  
Contravention due to default of other person. 
64.—(1) Where a contravention by any person of any provision to which this section applies 
constitutes an offence under this Act, and is due to an act or default of another person, then whether 
proceedings are taken against the first-mentioned person or not, that other person may be charged 
with and convicted of that offence and shall be  liable on conviction to the same punishment as might 
have been imposed on the first-mentioned person if  he had been convicted of the offence.   
 
(2) Where a person who is charged with an offence under this Act in respect of a contravention of a 
provision to which this section applies pr oves to the satisfaction of the court — 
 
(a) that he exercised all due diligence to secure  that the provision in question would not be 
contravened; and 
 
 (b) that the contravention was due to the act or default of another person, 
 the first-mentioned person shall be acquitted of the offence.    (3) This section applies to sections 31 to 33, 44 to 47 and 50 to 52 and the provisions of any 
regulations made under any of those sections.   
 
Warranty as defence. 
65.—(1) Subject to the following provisions of this  section, in any proceedings for an offence under 
this Act in respect of a contravention of a provision to which this section applies, it shall be a defence 
for the accused to prove — 
 
(a) that he purchased the substance or article to which the contravention relates in Singapore 
as being a substance or article which could be la wfully sold or supplied or could be lawfully 
sold or supplied under the name or description or for the purpose under or for which he sold 
or supplied and with a written warranty to that effect; 
 
(b) that at the time of the commission of the allege d offence he had no reason to believe that it 
was otherwise; and 
  (c) that the substance or article was then  in the same state as when he purchased it. 
 
(2) This section shall apply to section 31 (b), sections 32, 33 and 44 to 47 and the provisions of any 
regulations made under any of those sections.  (3) A warranty shall not be a defence by virtue of this section unless the defendant has, not later than 
7 clear days before the date of the hearing, sent to  the prosecution a copy of the warranty with a notice 
stating that he intends to rely on it and specify ing the name and address of the person from whom he 
received it, and has also sent a like notice to that person.  IP/N/1/SGP/U/2/Add.1 
Page 42  
 
  (4) Where the accused is a servant of the person who purchased the substance or article under the 
warranty, he shall be entitled to rely on this section in the same way as his employer would have been 
entitled to do if he had been charged with the offence.  (5) The person by whom the warranty is alleged to ha ve been given shall be entitled to appear at the 
hearing and to give evidence, and the court may, if it thinks fit, adjourn the hearing to enable him to 
do so.  (6) For the purposes of this section a name or descrip tion entered in an invoice shall be deemed to be 
a written warranty that the article or substance to wh ich the name or description applies can be sold or 
supplied under that name or description by any pe rson without contravening any provision to which 
this section applies.  
Offences in relation to warranties. 
66.—(1) If an accused in any such proceedings as ar e mentioned in section 65 (1) wilfully applies to 
any substance or article a warranty given in relation to a different s ubstance or article he shall be 
guilty of an offence.  (2) A person who, in respect of any substance or ar ticle sold by him in respect of which a warranty 
might be pleaded under section 65, gives to the purch aser a false warranty in writing shall be guilty of 
an offence, unless he proves that when he gave the warranty he had reason to believe that the 
statement or description contained in it was accurate. 
 (3) Any person guilty of an offence under this sec tion shall be liable on conviction to a fine not 
exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both.  Offences by bodies corporate. 
67.—(1) Where an offence under this Act committed by  a body corporate is proved to have been 
committed with the consent and connivance of, or to be  attributable to any neglect on the part of, any 
director, manager, secretary or other similar offi cer of the body corporate, or any person who was 
purporting to act in any such capacity, he as well as the body corporate shall be guilty of that offence 
and shall be liable to be proceeded against and punished accordingly.   
 
(2) In relation to a body corporate carrying on a retail pharmacy business, subsection (1) shall have 
effect in relation to a person who (not being such  an officer of the body corporate as is mentioned 
therein) –   
 (a) is the superintendent; or 
 
(b) at any premises where the business is ca rried on, is the pharmacist who acts under the 
directions of the superintendent, 
 as if he were such an officer of the body corporate. 
 
Certificate of analysis. 
68.—In any proceedings under this Act a certificate of analysis purporting to be signed by an analyst 
shall, on its production by the prosecution without proof of the signature of the analyst, be sufficient evidence of the facts stated therein until the contrary is proved.   IP/N/1/SGP/U/2/Add.1 
 Page 43 
 
 
  Presumptions. 
69.—(1) For the purposes of any proceedings under this Act for an offence consisting of –  
  (a) offering a medicinal product for sale by retail in contravention of section 24 or any 
conditions prescribed for th e purpose of section 25; or 
 
 (b) offering a medicinal product for sale in contravention of section 31 (b),  
 where it is proved that the medicinal product in qu estion was found on a vehicle or stall from which 
medicinal products are sold, it shall be presumed, unless the contrary is proved, that the person in 
charge of the vehicle or stall offered that medi cinal product for sale and, in a case falling within 
paragraph (a), that he offered it for sale by retail. 
 (2) For the purposes of any proceedings under this Act for an offence consisting of a contravention of 
so much of any provision to which this subsecti on applies as relates to a person having any medicinal 
product in his possession for the purpose of sale or supply, where it is proved that the medicinal 
product in question was found in any premises occupied by the person charged with the offence or under his control, it shall be presumed, unless the c ontrary is proved, that he had that medicinal 
product in his possession for the purpose of sale or supply.  (3) Subsection (2) shall apply to sections 31 (b), 44 (2) and (4), 46 (2) and 47 (3). 
 
(4) For the purposes of any proceedings under this Act for an offence consisting of a contravention of 
section 45 (2) or (3), as relates to leaflets, where it is proved that the leaflet in question was found in 
any premises occupied by the person charged with  the offence or under his control, it shall be 
presumed, unless the contrary is proved, that he ha d the leaflet in his possession for the purpose of 
supplying it with a medicinal product. 
 
Service of documents. 
70.—Any notice or other document required or author ised by any provision of this Act to be served 
on any person, or to be given or sent to an y person, may be served, given or sent –  
 
 (a) by delivering it to him; 
 
(b) by sending it by post to him at his usual or last-known residence or place of business in Singapore; or  
(c) in the case of a body corporate, by deliveri ng it to the secretary of the body corporate at its 
registered or principal office or sending it by post to the secretary of that body corporate at the office.  
Jurisdiction of District and Magistrate's Courts. 
71.—Notwithstanding anything to the contrary containe d in the Criminal Procedure Code, a District 
Court or Magistrate's Court shall have jurisdiction to try any offence under this Act and to impose the 
full penalty or punishment in respect of any such offence.  
Cap. 68. 
 Composition of offences. 
72.—The licensing authority may compound any offence under this Act or any regulations made 
thereunder by accepting from the person reasonably su spected of having committed such an offence a 
sum not exceeding $2,000.    IP/N/1/SGP/U/2/Add.1 
Page 44  
 
  Fees, charges, etc., collected by licensing auth ority to be paid to appropriate Authority. 
72A. —All fees, charges and other moneys recovered or  collected by the licensing authority under this 
Act or any regulations made thereunder (including  sums collected for the composition of offences 
under section 72) shall be paid –   
(a) in the case where the licensing authority is the Chief Executive of th e Authority, to the 
Authority; and 
 
(b) in the case where the licensing authority is  the Director-General, Agri-food and Veterinary 
Services, to the Agri-food and Veterinary Authority established under the Agri-food and 
Veterinary Authority Act 2000 (Act 16 of 2000). 
 
Advisory committees. 
73.—The Minister may establish one or more adviso ry committees consisting of such members as he 
may appoint for the purpose of giving advice to th e licensing authority with regard to such matters 
arising out of the administration of this Act as are referred to them by the Minister. 
 
Regulations. 
74.—(1) The Minister may make regulations for any purpose for which regulations are authorised or 
required to be made under this Ac t and generally for carrying out the purposes and provisions of this 
Act. 
 
(2) Without prejudice to the generality of subsecti on (1), regulations made under this Act may –  
 
(a) prescribe fees for the grant or renewal of licences and certificates; 
 
(b) prescribe standard provisions for licences and certificates either in respect of medicinal 
products generally or any class of medicinal products;  (c) provide for the registration of premises, othe r than pharmacies, used for the purpose of the 
retail sale, storage or supply of medicinal products;  
(d) provide that any person who contravenes the regulations shall be guilty of an offence and 
shall be liable on conviction to a fine not exceed ing $5,000 or to imprisonment for a term not 
exceeding 2 years or to both.  
Application of other written law not affected. 
75.—Except as expressly provided in this Act, nothing in this Act shall limit or affect in any way the 
provisions or operation of any other written law relating to any matter which may be dealt with in this 
Act.  
Repeal and consequential amendments. 
76*.—(1) The Medicines (Advertisement and Sale) Act and the Sale of Drugs Act are repealed and 
any subsidiary legislation made  under those Acts are revoked. 
Cap. 177. Cap. 282. 
 * This section was not in operation when th is Revised Edition was brought into force. 
 
Second Schedule. (2) The Poisons Act is amended in the manner set out in the Second Schedule. 
Cap. 234. 
  IP/N/1/SGP/U/2/Add.1 
 Page 45 
 
 
  Act not to apply to products categorised a nd regulated as health products under Health 
Products Act 2007. 
77.—(1) Where any product to which this Act applies has been categorised as a type of health product 
under the Health Products Act 2007, the Minister may, by order published in the Gazette , declare that 
the provisions of this Act shall cease to apply to th at type of product as from the date specified in the 
order, and the provisions of this Act shall, as from th e date so specified, cease to apply to that type of 
product.  (2) The Minister may, in making any order under s ubsection (1), prescribe such transitional, savings 
and other consequential provisions as he may consider necessary or expedient. 
 
 
FIRST SCHEDULE 
 
Section 51 (1) (a). 
 
DISEASES AND CONDITIONS 
 
 
1. Blindness.  
 2. Cancer. 
 3. Cataract. 
 
4. Drug addiction. 
 5. Deafness. 
 
6. Diabetes. 
 7. Epilepsy or fits. 
 8. Hypertension. 
 
9. Insanity. 
 10. Kidney diseases. 
 11. Leprosy. 
 
12. Menstrual disorders. 
 13. Paralysis. 
 
14. Tuberculosis. 
 15. Sexual function. 
 16. Infertility. 
 
17. Impotency. IP/N/1/SGP/U/2/Add.1 
Page 46  
 
   
18. Frigidity. 
 19. Conception and pregnancy. 
 
 
 
SECOND SCHEDULE* 
Section 76 (2). 
 
AMENDMENTS TO THE POIS ONS ACT (CHAPTER 234) 
 
1. In section 6 –  
 * This Schedule was not in operation when this Revised Edition was brought into force. 
 
 (a) delete the word "and" appearing at the end of subsection (1) (a) (iv); 
  (b) delete subsection (1) (a) (v); and 
 
(c) delete the words "or to some pharmacist in the employment of the seller at the premises 
where the sale is effected," appearing in the second, third and fourth lines of 
subsection (3) (a). 
 2. Section 7 is repealed. 
 
3. In section 9 (3), delete the words "or for di spensing purposes" appearing in the first and second 
lines.  4. In section 11 (1) –  
 
(a) delete the words "; or" appearing at the end of paragraph (c) and substitute therefor a full-
stop; and  
 
 (b) delete paragraph (d). 
 5. In section 17 (1), delete the words "section 7 a nd" appearing in the fourth line and substitute 
therefor the word "section".   
 6. In section 21 (1) -  
 
(a) delete the words " (c) or (d)" appearing in the third line of sub-paragraph (i) of 
paragraph (c); 
 
 (b) delete sub-paragr aph (ii) of paragraph (c); and 
  (c) delete paragraphs (g) and (l). 
  IP/N/1/SGP/U/2/Add.1 
 Page 47 
 
 
  7. After section 21, insert the following: 
 
  "Non-application of this Act to medicinal product or substance. 
22.—Nothing in this Act shall apply to an y poison which is incorporated in a 
medicinal product or used as a substan ce for a medicinal purpose and which is 
regulated by the provisions of the Medicines Act. 
 
Cap. 176.". 
 
Cap. 176 
 
 
__________